Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Show other versions (1)

Bibliographic Details
Main Authors:	Hyeon-Jeong Lee, Hye Jin Jang, Won-Il Choi, Joonsung Joh, Junghyun Kim, Jungeun Park, Miyoung Choi
Format:	Article
Language:	English
Published:	Korean Society of Critical Care Medicine 2023-11-01
Series:	Acute and Critical Care
Online Access:	http://www.accjournal.org/upload/pdf/acc-2022-01424-e1.pdf

Similar Items

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
by: Hyeon-Jeong Lee, et al.
Published: (2023-05-01)

Efficacy and safety of prone position in COVID-19 patients with respiratory failure: a systematic review and meta-analysis
by: Hyeon-Jeong Lee, et al.
Published: (2022-12-01)

Early intubation and clinical outcomes in patients with severe COVID-19: a systematic review and meta-analysis
by: Hyeon-Jeong Lee, et al.
Published: (2022-11-01)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
by: Sirui Zhang, et al.
Published: (2021-11-01)

Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry
by: Martin Grünewald MD, et al.
Published: (2021-05-01)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
by: Robin Rauniyar, et al.
Published: (2023-02-01)

Therapeutic or prophylactic anticoagulation in acute isolated distal deep vein thrombosis: protocol for a prospective, multicentre, single-blind, randomised controlled trial (TOP-IDDVT)
by: Min Zhou, et al.
Published: (2022-02-01)

Portomesenteric venous thrombosis in a prophylactically anticoagulated obese patient after laparoscopic sleeve gastrectomy: a case report
by: Feras Alsannaa, et al.
Published: (2021-12-01)

Safety of perioperative prophylactic anticoagulation in laparoscopic nephron-sparing surgery
by: Zhong Wenwen, Ye Lei, Qiu Wenfeng, Wang Dejuan, Qiu Jianguang
Published: (2022-07-01)

Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis
by: Hong Duo, et al.
Published: (2022-08-01)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
by: Tess Van Meerhaeghe, et al.
Published: (2022-10-01)

Prophylactic Versus Therapeutic Antibiotic Therapy Following Appendicectomy
by: Muqdad Fuad Abdulkareem, et al.
Published: (2018-08-01)

Prophylactic Versus Therapeutic Antibiotic Therapy Following Appendicectomy
by: Muqdad Fuad Abdulkareem, et al.
Published: (2018-08-01)

Thrombosis Prevention without Anticoagulation
by: Alvin H. Schmaier
Published: (2014-05-01)

Comparison of Treatment Result Between Anticoagulation Alone and Catheter-Directed Thrombolysis Plus Anticoagulation in Acute Lower Extremity Deep Vein Thrombosis
by: Young Jin Choi, et al.
Published: (2019-03-01)

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation (Russian Translation of Cochrane Plain Language Summary – PLS)
by: Elvira G. Alexandrova
Published: (2020-12-01)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
by: Neil A. Zakai, et al.
Published: (2021-08-01)

Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
by: Yasir Khan, et al.
Published: (2019-11-01)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
by: Sarah Kelddal, et al.
Published: (2019-04-01)

Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment
by: Chenyang Zhan, et al.
Published: (2021-05-01)

Influence of multiple stenoses on thrombosis formation: an in vitro study
by: Helem B. Flores Marcial, et al.
Published: (2022-11-01)

EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01)

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
by: David M. Smadja, et al.
Published: (2021-10-01)

Safety and efficacy of prophylactic tirofiban infusion for acute intracranial intraprocedural stent thrombosis
by: Lili Sun, et al.
Published: (2021-10-01)

PREVENTION AND TREATMENT OF THROMBOSIS AND THROMBOEMBOLIAS WITH ORAL ANTICOAGULANTS
by: G. V. Arkadyeva
Published: (2003-12-01)

Thrombophilic states and anticoagulants in portal vein thrombosis
by: Madhumita Nandi
Published: (2016-01-01)

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
by: Steven P. Grover, et al.
Published: (2022-05-01)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
by: Tsuyoshi Suda, et al.
Published: (2020-09-01)

Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review
by: Cristian-Mihail Niculae, et al.
Published: (2023-07-01)

Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model
by: Hye Ryeon Yang, et al.
Published: (2022-08-01)

Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis
by: Stefanie Reis, et al.
Published: (2021-12-01)

The Therapeutic Potential of Anticoagulation in Organ Fibrosis
by: Hanna Oh, et al.
Published: (2022-05-01)

Deficiency of Natural Anticoagulants Involves in the Occurrence of Arterial Thrombosis
by: Thi Tuyet Mai Nguyen MD, et al.
Published: (2023-11-01)

MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
by: V. I. Petrov, et al.
Published: (2014-08-01)

Direct oral anticoagulants for the treatment of Cancer-Associated Thrombosis
by: Łukasz Ledziński, et al.
Published: (2021-09-01)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
by: Wolfgang Miesbach MD, et al.
Published: (2020-07-01)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01)

Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome
by: Mari Okada, et al.
Published: (2017-07-01)

Clinical Value Evaluation of Perioperative Prophylactic Anticoagulation Therapy for Lung Cancer Patients
by: Hui XU, et al.
Published: (2018-10-01)

Long term anticoagulant therapy with varfarin efficacy and safety in patients with venous thrombosis
by: T Y Kozlova
Published: (2005-08-01)